KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogenomics (NEO) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for Neogenomics (NEO) over the last 17 years, with Q3 2025 value amounting to -$27.1 million.

  • Neogenomics' Income from Continuing Operations fell 5327.98% to -$27.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$113.5 million, marking a year-over-year decrease of 4598.09%. This contributed to the annual value of -$78.7 million for FY2024, which is 1050.61% up from last year.
  • Neogenomics' Income from Continuing Operations amounted to -$27.1 million in Q3 2025, which was down 5327.98% from -$45.1 million recorded in Q2 2025.
  • In the past 5 years, Neogenomics' Income from Continuing Operations ranged from a high of $75.9 million in Q2 2021 and a low of -$49.4 million during Q1 2022
  • For the 5-year period, Neogenomics' Income from Continuing Operations averaged around -$22.0 million, with its median value being -$24.3 million (2023).
  • Within the past 5 years, the most significant YoY rise in Neogenomics' Income from Continuing Operations was 121185.52% (2021), while the steepest drop was 89577.63% (2021).
  • Over the past 5 years, Neogenomics' Income from Continuing Operations (Quarter) stood at -$41.8 million in 2021, then soared by 45.67% to -$22.7 million in 2022, then surged by 36.85% to -$14.3 million in 2023, then dropped by 6.97% to -$15.3 million in 2024, then crashed by 77.04% to -$27.1 million in 2025.
  • Its Income from Continuing Operations stands at -$27.1 million for Q3 2025, versus -$45.1 million for Q2 2025 and -$25.9 million for Q1 2025.